3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Ovarian Neoplasms
4
Endometrial Neoplasms
4
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Interventions
Cisplatin
3
pembrolizumab
2
amminedichloro(2-methylpyridine)platinum(II)
2
Nivolumab
2
Cytoreduction Surgical Procedures
2
trastuzumab deruxtecan
1
trametinib
1
sodium thiosulfate
1
pertuzumab
1
pazopanib
1
osimertinib
1
motexafin gadolinium
1
fludarabine
1
danvatirsen
1
dabrafenib
1
cobimetinib
1
cemiplimab
1
alectinib
1
aldesleukin
1
X-Rays
1
Ritonavir
1
Remote Patient Monitoring
1
Patient-Specific Modeling
1
Pafolacianine
1
Oxaliplatin
1
Observation
1
Mitomycin
1
Microscopy, Electron
1
Itraconazole
1
Hyperthermic Intraperitoneal Chemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
trastuzumab deruxtecan
×
Gynecologic
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled